AGP Wire

AGP

The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.

AGP

The Business Research Company says the global Admelog market is set for long-term growth through 2035, driven by rising diabetes cases, expanding biosimilar use and government efforts to contain insulin costs.

AGP

The Business Research Company says the global Adcetris market is expanding on rising cancer cases, demand for targeted therapies and broader use in oncology.

AGP

The Business Research Company says the global ADZYNMA market is set for a new growth phase through 2035, driven by rare-disease awareness, genetic screening and broader access to targeted therapies.

AGP

The Business Research Company says the global Adlyxin (Lyxumia) market is expanding as type 2 diabetes and obesity rates rise, with North America leading in 2025 and Asia-Pacific set for the fastest growth through 2035. The report also highlights…

AGP

Aker BioMarine will host the next stop of its Vitality Month 2026 program in Mexico City on Oct. 8, gathering nutrition, ingredient and health industry experts at Centro Banamex.

AGP

ATELIER Playa Mujeres, its NUUP Spa, and María Dolores by Edgar Núñez earned nine distinctions at the 2026 World Luxury Awards in Cancún, Mexico.

AGP

The acute spinal cord injury market is projected to grow from $7.43 billion in 2026 to $9.4 billion by 2030, according to The Business Research Company.

AGP

The acute pharyngitis market is projected to rise from $2.89 billion in 2025 to $3.13 billion in 2026, with The Business Research Company forecasting $4.25 billion by 2030. Rising influenza and respiratory infections, along with telemedicine and…

AGP

Miracle Surrogacy finished a free six-webinar series that drew 620 registrations and more than 250 live attendance instances from audiences around the world.

AGP

The ADME toxicology testing market is projected to grow from $11.5 billion in 2025 to $20.25 billion by 2030, driven by rising drug development activity, tighter safety rules and broader use of advanced testing tools.

AGP

The Business Research Company says the global Adbry/Adtralza market has growth potential through 2030, driven by rising atopic dermatitis cases, broader biologic use and improving reimbursement.

AGP

The Business Research Company says the Advate market will keep expanding through 2035, driven by rising hemophilia A diagnoses, broader use of prophylactic therapy, and growing preference for home-based care.

AGP

Mexico’s CONASAMA has recognized three Narconon residential rehab centers for meeting federal standards on addiction treatment, patient rights and facility oversight.

AGP

The Business Research Company says the Aduhelm market is expanding as Alzheimer’s cases rise, diagnosis improves and demand grows for disease-modifying therapies.

AGP

The Business Research Company says the global Adagen market is set for steady growth, rising from $0.09 million in 2025 to $0.1 million in 2026 and reaching $0.13 million by 2030. The report points to rising precision medicine use, more rare…

AGP

The acute renal failure market is projected to grow from $6.6 billion in 2025 to $9.71 billion by 2030, driven by higher rates of diabetes, hypertension and chronic kidney disease.

AGP

Hotel Matilda was named the No. 5 hotel in Mexico in Condé Nast Traveler’s 2026 Readers’ Choice Awards and the No. 1 hotel in San Miguel de Allende.

AGP

Tres centros de rehabilitación residencial Narconon en México получили reconocimiento federal de CONASAMA tras una revisión de cumplimiento con normas aplicables al tratamiento de adicciones.

AGP

The addictions therapeutics market is projected to grow from $7.46 billion in 2025 to $7.93 billion in 2026, with North America holding the largest regional share.